J
Joseph Leo Ghislanus Torremans
Researcher at Janssen Pharmaceutica
Publications - 23
Citations - 574
Joseph Leo Ghislanus Torremans is an academic researcher from Janssen Pharmaceutica. The author has contributed to research in topics: Bicyclic molecule & Astemizole. The author has an hindex of 11, co-authored 22 publications receiving 571 citations.
Papers
More filters
Patent
4-[(Bicyclic heterocyclyl)-methyl and -hetero]-piperidines
Frans Eduard Janssens,Ludo Edmond Josephine Kennis,Jozef Francis Hens,Joseph Leo Ghislanus Torremans,Gaston Stanislas Marcella Diels +4 more
TL;DR: In this paper, 4.4-[(Bicyclic heterocyclyl)methyl and -hetero]-piperidines having antihistaminic and serotonin-antagonistic properties are useful agents in the treatment of allergic diseases.
Journal ArticleDOI
New antihistaminic N-heterocyclic 4-piperidinamines. 1. Synthesis and antihistaminic activity of N-(4-piperidinyl)-1H-benzimidazol-2-amines.
Janssens Frans Eduard,Joseph Leo Ghislanus Torremans,Marcel Janssen,Raymond Antoine Stokbroekx,Marcel Gerebernus Maria Luyckx,Paul A. J. Janssen +5 more
TL;DR: The phenylethyl derivatives showed the most potent antihistamine properties after oral administration in both animal species and in vivo antihistaminic activity was evaluated.
Patent
N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives
Frans Eduard Janssens,Joseph Leo Ghislanus Torremans,Jozef Francis Hens,Theophilus Theresia J.M. Van Offenwert +3 more
TL;DR: Novel N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives having antihistaminic properties which compounds are useful in the treatment of allergic diseases.
Journal ArticleDOI
New antihistaminic N-heterocyclic 4-piperidinamines. 2. Synthesis and antihistaminic activity of 1-[(4-fluorophenyl)methyl]-N-(4-piperidinyl)-1H-benzimidazol-2-a mines.
Janssens Frans Eduard,Joseph Leo Ghislanus Torremans,Marcel Janssen,Raymond Antoine Stokbroekx,Marcel Gerebernus Maria Luyckx,Paul A. J. Janssen +5 more
TL;DR: The synthesis of a series of 1-[(4-fluorophenyl)methyl]-N-(4-piperidinyl)-1H-benzimidazol-2-ami nes and the preliminary evaluation of their in vivo antihistamine activity are described and Astemizole has been selected for clinical investigation.
Journal ArticleDOI
New antihistaminic N-heterocyclic 4-piperidinamines. 3. Synthesis and antihistaminic activity of N-(4-piperidinyl)-3H-imidazo[4,5-b]pyridin-2-amines.
Janssens Frans Eduard,Joseph Leo Ghislanus Torremans,Marcel Janssen,Raymond Antoine Stokbroekx,Marcel Gerebernus Maria Luyckx,Paul A. J. Janssen +5 more
TL;DR: To study the bioisosteric replacement of a 2-pyridyl ring for a phenyl nucleus in astemizole, a series of N-(4-piperidinyl)-3H-imidazo[4,5-b]pyridine-2-amines was synthesized and evaluated.